Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | LRRCC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | TMEM74 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ZNF708 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |